DRG Debuts Calprotectin Poster at MEDLAB Asia Pacific 2017!
DRG Booth with Visitors. From Left: Mr. Gideon Lim; Dr. Cyril E. Geacintov, CEO & Founder of DRG; Dr.Aw Tar Choon, MD at Changi General Hospital in Singapore; Mrs. Josephine Teo; Mrs. Elke Geacintov; Mr. Wilhelm Sanger.
We are pleased to announce that the DRG Group successfully exhibited at MEDLAB Asia Pacific 2017. The show took place in Singapore at The Suntec Expo and Convention Centre, from April 3 – 5, 2017, and DRG exhibited at Booth #Q11.
DRG Founder, President, & CEO Dr. Cyril E. Geacintov was at the DRG booth and met with several customers and distributors. DRG’s Singapore distributor BioMedix helped DRG maintain the booth, BioMedix owners Mr. Gideon Lim and Ms. Josephine Teo pictured above.
DRG also featured a poster presentation at Medlab Asia Pacific 2017 entitled “Validation of Fecal Calprotectin on the DRG:Hybrid-XL Analyzer.” You can find a link to the poster here. The study concluded that the DRG:Hybrid-XL analyzer is the first fully automated system for the quantification of Calprotectin in stool samples. The fecal calprotectin test shows diagnostic advantages over standard fecal occult blood screening in colorectal cancer and is a much better predictor of relapse.
DRG offered live demonstrations of our fully automated random access analyzer: DRG:HYBRiD-XL®. DRG is also proud to highlight our newest ELISAs like DHT-optimized and Hepcidin 25 (bioactive) High Sensitive ELISA kit.
To learn more about DRG’s Hepcidin kit or the DRG:HYBRiD-XL®, please visit our site here!
Latest posts by Gregory C. Guest (see all)
- DRG Debuts Calprotectin Poster at MEDLAB Asia Pacific 2017! - April 21, 2017
- DRG CA 72-4 ELISA Kit Used in Winthrop University Study - March 15, 2017
- DRG International to Exhibit at Medlab Dubai 2017 - February 3, 2017
News and Updates
DRG’s CA 72-4 ELISA Kit (EIA-5071), which uses antibodies licensed from the NIH, has been used in a recent study conducted by Winthrop University. The study used the DRG CA 72-4 ELISA Kit (EIA-5071) to explore the expression of CA72-4 compared to current FDA-approved...read more
DRG is pleased to officially announce that we are going to Medlab Dubai from February 6th-February 9th, 2017 at the Dubai International Convention & Exhibition Centre, attended by over 10,000 delegates. The conference features 11 CME-accredited conference...read more
We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked them questions about what makes them the worldwide leader in diagnostics. These are the key takeaways the top executives at DRG want you to remember. Michael Martini (full...read more
DRG’s staff is diverse and the company maintains a global presence requiring its staff to speak multiple languages as well as travel the world visiting DRG’s many offices and events. We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting...read more
We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked them each about what DRG’s strengths are and how they add value to customers and business partners. Wilhelm Saenger (full profile) Our flexibility, flexibility and...read more
As a worldwide leader in diagnostics with several locations spanning the globe, DRG is proud to have a diverse, multilingual staff. We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked each of them about the languages they...read more
Maximilian Saenger, son of the General Manager of DRG Germany (Wilhelm Saenger), traveled to Bishkek, capital of Kyrgyz Republic, during his summer vacation in August 2016.read more
We sat down with top members of the DRG International team at the AACC Convention 2016 in Philadelphia, PA, US and discuss innovation in the diagnostic testing field.read more
The 25-OH Vitamin D total ELISA (EIA-5396) was recently awarded the 2015-2016 Certificate of Proficiency by the Vitamin D External Quality Assessment Scheme (DEQAS) Advisory Panel.read more
Chromogenics was first introduced to the public with the invention and patent for detecting E. coli bacteria by method of “chromogenic differentiation” culture media.read more
The DRG:HYBRID-XL fully automated random access analyzer is the perfect fit for medium or small laboratories. Its compact size can deliver to large demand and can be your primary machine to provide diagnostics to clients.read more
DRG International, Inc. recently exhibited at ENDO EXPO 2016, the largest meeting of endocrine practitioners and researchers, from April 1 – 3 at the Boston Convention & Exhibition Center in Boston, MA.read more